RU2578031C2 - Птеростильбен (pter) для применения в профилактике и/или лечении кожных заболеваний, повреждений или травм - Google Patents

Птеростильбен (pter) для применения в профилактике и/или лечении кожных заболеваний, повреждений или травм Download PDF

Info

Publication number
RU2578031C2
RU2578031C2 RU2012122241/15A RU2012122241A RU2578031C2 RU 2578031 C2 RU2578031 C2 RU 2578031C2 RU 2012122241/15 A RU2012122241/15 A RU 2012122241/15A RU 2012122241 A RU2012122241 A RU 2012122241A RU 2578031 C2 RU2578031 C2 RU 2578031C2
Authority
RU
Russia
Prior art keywords
pter
skin
quer
exposure
pterostilbene
Prior art date
Application number
RU2012122241/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2012122241A (ru
Inventor
АРИКЕЛЬ Хосе Мария ЭСТРЕЛА
МИРАЛЛЕС Мигель А. АСЕНСИ
Original Assignee
Грин Молекьюлар, С.Л
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Грин Молекьюлар, С.Л filed Critical Грин Молекьюлар, С.Л
Publication of RU2012122241A publication Critical patent/RU2012122241A/ru
Application granted granted Critical
Publication of RU2578031C2 publication Critical patent/RU2578031C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C07C43/166—Unsaturated ethers containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
RU2012122241/15A 2009-10-30 2010-10-29 Птеростильбен (pter) для применения в профилактике и/или лечении кожных заболеваний, повреждений или травм RU2578031C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09174717A EP2322159A1 (en) 2009-10-30 2009-10-30 Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic
EP09174717.0 2009-10-30
PCT/EP2010/066544 WO2011051483A1 (en) 2009-10-30 2010-10-29 Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or injures

Publications (2)

Publication Number Publication Date
RU2012122241A RU2012122241A (ru) 2013-12-10
RU2578031C2 true RU2578031C2 (ru) 2016-03-20

Family

ID=42320589

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012122241/15A RU2578031C2 (ru) 2009-10-30 2010-10-29 Птеростильбен (pter) для применения в профилактике и/или лечении кожных заболеваний, повреждений или травм

Country Status (14)

Country Link
US (3) US20130136778A1 (ja)
EP (2) EP2322159A1 (ja)
JP (2) JP2013509385A (ja)
KR (1) KR101795495B1 (ja)
CN (1) CN102639126B (ja)
AU (2) AU2010311326B2 (ja)
BR (1) BR112012010070A2 (ja)
CA (1) CA2778151C (ja)
DK (1) DK2493462T3 (ja)
ES (1) ES2432236T3 (ja)
IL (1) IL219318A (ja)
MX (1) MX2012005013A (ja)
RU (1) RU2578031C2 (ja)
WO (1) WO2011051483A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9439875B2 (en) * 2011-05-11 2016-09-13 The United States Of America, As Represented By The Secretary Of Agriculture Anxiolytic effect of pterostilbene
US8841350B2 (en) * 2011-05-11 2014-09-23 ChromaDex Inc. Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
JP5901547B2 (ja) * 2012-03-28 2016-04-13 富士フイルム株式会社 組成物、これを含む皮膚外用剤、又は機能性食品
ES2506243T3 (es) * 2012-09-05 2014-10-13 Psoriasis+Creams Sweden Ab Composición para tratar la psoriasis
WO2014085914A1 (en) * 2012-12-06 2014-06-12 Misudan Enterprises Inc. Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
US20160067193A1 (en) * 2014-09-04 2016-03-10 The Regents Of The University Of California Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasia
CN107106877A (zh) 2014-09-04 2017-08-29 加利福尼亚大学董事会 用于治疗uv诱发的皮肤屏障功能受损的局部用蝶芪组合物
RU2017145692A (ru) * 2015-06-10 2019-07-10 Элизиум Хелт, Инк. Композиции никотинамида рибозида и птеростильбена и способы лечения заболеваний кожи
CN108653303A (zh) * 2018-04-02 2018-10-16 青岛科技大学 一种具有提供弱酸性胶束微环境的高稳定型紫檀芪滴眼液及其制备方法
CN108653304A (zh) * 2018-04-04 2018-10-16 青岛科技大学 一种紫檀芪纳米胶束外用凝胶及其制备方法
JP2020069470A (ja) * 2018-10-29 2020-05-07 株式会社げんてん本店 リポソームの製造方法、及び、リポソーム含有液の製造方法
KR20200052191A (ko) 2018-11-06 2020-05-14 한국식품연구원 후각수용체 특이적 리간드 및 그 용도
WO2020263189A1 (en) * 2019-06-25 2020-12-30 Agency For Science, Technology And Research Phenols that decrease lipid production in sebocytes
CN115040420A (zh) * 2022-07-18 2022-09-13 云南贝泰妮生物科技集团股份有限公司 一种紫檀芪脂质体及其制备方法
US20240130945A1 (en) * 2022-10-20 2024-04-25 Innovation Hammer Llc Methods and formulations for mitigating damaging effects from exposure to uv radiation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139803A (en) * 1989-02-09 1992-08-18 Nabisco, Inc. Method and liposome composition for the stabilization of oxidizable substances
WO2001043705A2 (en) * 1999-12-16 2001-06-21 Johnson & Johnson Consumer Companies, Inc. Compositions containing a retinoid and a stilbene for skin care
WO2004037184A2 (en) * 2002-10-24 2004-05-06 The Quigley Corporation Methods for the treatment of skin disorders
EP1782802A1 (en) * 2004-07-20 2007-05-09 Universidad de Valencia Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments
RU2357724C1 (ru) * 2007-10-22 2009-06-10 Институт химии нефти Сибирского отделения Российской академии наук Способ получения магниточувствительных липосом

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944313A (ja) * 1982-09-07 1984-03-12 Yakult Honsha Co Ltd 抗菌性組成物
DE10161253A1 (de) * 2001-12-13 2003-06-26 Dragoco Gerberding Co Ag Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren
CN1269782C (zh) * 2003-10-24 2006-08-16 中国科学院广州化学研究所 紫檀芪的合成方法
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform
US7776915B2 (en) 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
WO2008067928A1 (en) 2006-12-04 2008-06-12 Isdin S.A. Uv absorbing compositions containing a pyrrolyltriazine
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US20090163580A1 (en) * 2007-12-24 2009-06-25 Natrol, Inc. Anti-aging composition containing resveratrol and method of administration
US20100240767A1 (en) * 2009-03-23 2010-09-23 Muhammed Majeed Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
CN101912377A (zh) * 2010-08-10 2010-12-15 王晓琴 紫檀芪在制备抗宫颈癌药物中的应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139803A (en) * 1989-02-09 1992-08-18 Nabisco, Inc. Method and liposome composition for the stabilization of oxidizable substances
WO2001043705A2 (en) * 1999-12-16 2001-06-21 Johnson & Johnson Consumer Companies, Inc. Compositions containing a retinoid and a stilbene for skin care
WO2004037184A2 (en) * 2002-10-24 2004-05-06 The Quigley Corporation Methods for the treatment of skin disorders
EP1782802A1 (en) * 2004-07-20 2007-05-09 Universidad de Valencia Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments
RU2357724C1 (ru) * 2007-10-22 2009-06-10 Институт химии нефти Сибирского отделения Российской академии наук Способ получения магниточувствительных липосом

Also Published As

Publication number Publication date
US20160158164A1 (en) 2016-06-09
IL219318A0 (en) 2012-06-28
AU2010311326B2 (en) 2016-10-06
WO2011051483A1 (en) 2011-05-05
KR20120094167A (ko) 2012-08-23
AU2016234952B2 (en) 2018-08-16
JP5905979B2 (ja) 2016-04-20
US20180008555A1 (en) 2018-01-11
EP2493462B1 (en) 2013-07-24
BR112012010070A2 (pt) 2016-05-31
KR101795495B1 (ko) 2017-12-01
AU2016234952A1 (en) 2016-10-13
RU2012122241A (ru) 2013-12-10
JP2013509385A (ja) 2013-03-14
CA2778151A1 (en) 2011-05-05
CN102639126A (zh) 2012-08-15
AU2010311326A1 (en) 2012-05-17
EP2322159A1 (en) 2011-05-18
IL219318A (en) 2016-03-31
JP2016006060A (ja) 2016-01-14
MX2012005013A (es) 2012-08-15
DK2493462T3 (da) 2013-10-28
US20130136778A1 (en) 2013-05-30
EP2493462A1 (en) 2012-09-05
CA2778151C (en) 2017-03-07
CN102639126B (zh) 2018-07-06
ES2432236T3 (es) 2013-12-02

Similar Documents

Publication Publication Date Title
RU2578031C2 (ru) Птеростильбен (pter) для применения в профилактике и/или лечении кожных заболеваний, повреждений или травм
Vasanth et al. Development and investigation of vitamin C-enriched adapalene-loaded transfersome gel: a collegial approach for the treatment of acne vulgaris
Paolino et al. Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses
RU2654804C2 (ru) Антиоксидантные композиции и способы их применения
EP1891929A1 (en) Skin cosmetic and wrinkle-reducing agent
KR20180036580A (ko) 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
JP2003306446A (ja) 皮膚老化防止剤及び／又はニキビ改善剤キット
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
WO2011021892A2 (ko) 헥사미딘류 및 레티노이드류를 함유하는 피부 개선 조성물
EP1872764B1 (en) Use of a sugar alcohol in cosmetic compositions for skin and wrinkle improver
US20180311133A1 (en) Composition comprising melatonin or its derivatives with coenzyme q10 and use thereof against ageing of the skin
JP4541699B2 (ja) カルボキシレート−ゲート−ニトロキシド（ｃｇｎ）化合物および組成物ならびにその使用方法
Parveen et al. Drug permeation enhancement, efficacy, and safety assessment of azelaic acid loaded SNEDDS hydrogel to overcome the treatment barriers of atopic dermatitis
US8314070B2 (en) Osmoprotective complexes for prevention of intra-cellular dehydration in mammals
KR101957411B1 (ko) 생약 추출물 함포 펙틴 마이크로캡슐을 포함하는 피부 개선용 화장료 조성물
JP2013032331A (ja) 脂質産生抑制剤、皮脂産生抑制剤およびトリアシルグリセロール産生抑制剤
BR102015016405A2 (pt) Polymeric nanoparticles containing red propolis extract, process for obtaining polymer nanoparticles, dermochemical compositions containing the same, process for obtaining compositions and uses
Mancuso et al. Improvement of ferulic acid antioxidant activity by multiple emulsions
EP2314277B1 (en) External preparation for skin, and wrinkle-repairing agent
Pandya et al. Role of Lipids in Cosmeceuticals
KR20240007076A (ko) 페길화된 빌리루빈을 포함하는 염증성 질환의 예방또는 치료용 약학 조성물
US8496916B2 (en) Sunscreen composition with polyhydroxy quaternary ammonium salts
JPH0840866A (ja) ラブドシンまたはその塩を含有する化粧料
BR102016018124A2 (pt) Nanoesferas carregadas extrato de própolis vermelha, processo de obtenção de nanoesferas, composições dermocosméticas contendo as mesmas e usos

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20201030